Cargando…

Multiple drugs: COVID-19 and impaired humoral immunity: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683307/ http://dx.doi.org/10.1007/s40278-021-07541-0

Ejemplares similares

Monoclonal antibodies: Impaired humoral immunity: 5 case reports
Publicado: (2020)

Multiple drugs: COVID-19: case report
Publicado: (2021)

Cellular and Humoral Immune Responses to Vaccination for COVID-19 Are Negatively Impacted by Senescent T Cells: A Case Report
por: Rosseto-Welter, Eliane Aparecida, et al.
Publicado: (2023)

Compassionate use of REGN-COV2 in the treatment of COVID-19 in a patient with impaired humoral immunity
por: Nguyen, Hanna, et al.
Publicado: (2021)

Multiple drugs: COVID-19: 4 case reports
Publicado: (2021)

Multiple drugs: COVID-19 prolongation: case report
Publicado: (2021)

Multiple drugs: COVID-19 and COVID-19 pneumonia: 4 case reports
Publicado: (2021)

Multiple drugs: COVID-19 pneumonia: 4 case reports
Publicado: (2021)

Multiple drugs: COVID-19 infection: 4 case reports
Publicado: (2021)

Multiple drugs: COVID-19 infection: 15 case reports
Publicado: (2021)

Multiple drugs: Covid-19 reinfection: 2 case reports
Publicado: (2021)

Multiple drugs: COVID-19 infection: 6 case reports
Publicado: (2021)

Multiple drugs: COVID-19 infection: 4 case reports
Publicado: (2020)

Multiple drugs: Lymphopaenia and COVID-19 infection: case report
Publicado: (2020)

Multiple drugs: COVID‑19 infection: 6 case report
Publicado: (2022)

Multiple drugs: COVID-19 infection: 5 case reports
Publicado: (2022)

Multiple drugs: Lethal COVID-19 and lack of efficacy: case report
Publicado: (2021)

Multiple drugs: Prolonged COVID-19 viral shedding: case report
Publicado: (2021)

Multiple drugs: Neutropenia and COVID-19 infection: 4 case reports
Publicado: (2020)

Multiple drugs: COVID-19 and Streptococcus pneumoniae infection: case report
Publicado: (2022)

Rituximab: Humoral immunodeficiency: case report
Publicado: (2021)

Multiple drugs: COVID-19 reinfection, COVID-19 reactivation and differentiation syndrome: case report
Publicado: (2021)

Multiple drugs: Immune thrombocytopenia and lack of efficacy: case report
Publicado: (2021)

Multiple drugs: COVID-19 infection and lack of efficacy: 8 case reports
Publicado: (2021)

Multiple drugs: COVID-19 infection and off-label use: case report
Publicado: (2021)

Multiple drugs: Lack of efficacy and COVID-19 associated encephalopathy: case report
Publicado: (2021)

Multiple drugs: COVID-19 and off-label use: 22 case reports
Publicado: (2021)

Multiple drugs: Pancytopenia, COVID-19 and off-label use: case report
Publicado: (2020)

Multiple drugs: COVID-19 and off-label use: 2 case reports
Publicado: (2020)

Multiple drugs: Prolonged course of COVID 19 infection and hypogammaglobulinaemia: case report
Publicado: (2022)

Multiple drugs: COVID-19 pneumonia and lack of efficacy: 3 case reports
Publicado: (2022)

Multiple drugs: COVID-19 infection and lack of efficacy: 6 case reports
Publicado: (2022)

Multiple drugs: COVID-19 pneumonia and compassionate use of clazakizumab for COVID-19 pneumonia: case report
Publicado: (2020)

Multiple drugs: Impaired vaccine response secondary to pharmacodynamic interaction: 3 case reports
Publicado: (2021)

Multiple drugs: Immune mediated colitis and treatment failure: case report
Publicado: (2021)

Multiple drugs: Prothrombotic immune thrombocytopenia and lack of efficacy: case report
Publicado: (2022)

Multiple drugs: COVID-19-pneumonia and increase in drug levels due to interactions: 2 case reports
Publicado: (2021)

Multiple drugs: COVID-19 infection, drug induced psychosis and off-label use: case report
Publicado: (2021)

Multiple drugs: Various toxicities: 19 case reports
Publicado: (2022)

Multiple drugs: COVID-19-associated pulmonary aspergillosis infection: 8 case reports
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5op9iqa6sqramdji9k6jjce1im